Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 12, 2017 Filed May 15, 2017 20:45 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Tax withholdingHumana Common 1,281 $229.77 $294,328.97
Disclosure

SEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 4

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,003

F10 · price: Shares swapped for payment of purchase price on incentive stock option exercises using fair market value on May 11, 2017, pursuant to Humana Inc.'s 2011 Stock Incentive Plan.

Read SEC document
May 12, 2017 Filed May 15, 2017 20:45 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionHumana Common 26,023 $231.99 $6,037,172.06
Disclosure

SEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 3

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,284

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · price: Shares sold at prices ranging from $231.88 to $232.10.

Read SEC document
May 12, 2017 Filed May 15, 2017 20:45 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionHumana Common 15,086 $102.16 $1,541,110.33
Disclosure

SEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 2

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,037

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2017 Filed May 15, 2017 20:45 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionHumana Common 14,290 $81.80 $1,168,850.55
Disclosure

SEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 1

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,221

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2017 Filed May 9, 2017 17:47 UTC
BILNEY JODY LSVP & Chief Consumer Officer
SaleHumana Common 4,600 $230.16 $1,058,743.36
Disclosure

SEC source: 0000049071-17-000110 · edgar.xml · nonDerivative · entry 1

BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,978

F8 · price: All shares sold at this price.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:05 UTC
Huval Timothy S.Senior VP & Chief HR Officer
Exercise / conversionOptions · Derivative 6,934 $0.00 Strike: $167.81 $0.00
Disclosure

SEC source: 0000049071-17-000107 · edgar.xml · derivative · entry 5

Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,870

Underlying: Humana Common · 6,934 shares

Expires 2023-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.

F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:05 UTC
Huval Timothy S.Senior VP & Chief HR Officer
Exercise / conversionOptions · Derivative 7,005 $0.00 Strike: $164.65 $0.00
Disclosure

SEC source: 0000049071-17-000107 · edgar.xml · derivative · entry 4

Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,005

Underlying: Humana Common · 7,005 shares

Expires 2022-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:05 UTC
Huval Timothy S.Senior VP & Chief HR Officer
SaleHumana Common 13,939 $225.86 $3,148,305.75
Disclosure

SEC source: 0000049071-17-000107 · edgar.xml · nonDerivative · entry 3

Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,634

F7 · price: Shares sold at prices ranging from $225.10 to $226.67. Price reported is the average sale price.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:05 UTC
Huval Timothy S.Senior VP & Chief HR Officer
Exercise / conversionHumana Common 6,934 $167.81 $1,163,559.87
Disclosure

SEC source: 0000049071-17-000107 · edgar.xml · nonDerivative · entry 2

Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,573

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:05 UTC
Huval Timothy S.Senior VP & Chief HR Officer
Exercise / conversionHumana Common 7,005 $164.65 $1,153,338.23
Disclosure

SEC source: 0000049071-17-000107 · edgar.xml · nonDerivative · entry 1

Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,639

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:04 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionOptions · Derivative 39,147 $0.00 Strike: $167.81 $0.00
Disclosure

SEC source: 0000049071-17-000106 · edgar.xml · derivative · entry 5

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,294

Underlying: Humana Common · 39,147 shares

Expires 2023-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.

F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:04 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionOptions · Derivative 79,084 $0.00 Strike: $164.65 $0.00
Disclosure

SEC source: 0000049071-17-000106 · edgar.xml · derivative · entry 4

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,542

Underlying: Humana Common · 79,084 shares

Expires 2022-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:04 UTC
BROUSSARD BRUCE DDirector · President & CEO
SaleHumana Common 118,231 $225.82 $26,699,149.06
Disclosure

SEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 3

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,086

F7 · price: Shares sold at prices ranging from $224.65 to $228.71. Price reported is the average sale price.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:04 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionHumana Common 39,147 $167.81 $6,569,062.34
Disclosure

SEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 2

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2017 Filed May 4, 2017 20:04 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionHumana Common 79,084 $164.65 $13,020,785.18
Disclosure

SEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 1

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,170

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2017 Filed Apr 3, 2017 21:05 UTC OtherPhantom Stock Units · Derivative 5 $201.66 $1,008.30
Disclosure

SEC source: 0000049071-17-000090 · edgar.xml · derivative · entry 7

MURRAY JAMES E · CIK 0001018658 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 205

Underlying: Humana Common · 5 shares

Expires not disclosed

F7 · security: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 20:21 UTC GrantStock Unit · Derivative 371 $206.42 $76,581.82
Disclosure

SEC source: 0000049071-17-000092 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,195

Underlying: Humana Common · 371 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 31, 2017 Filed Apr 4, 2017 20:16 UTC GrantStock Unit · Derivative 150 $206.42 $30,963.00
Disclosure

SEC source: 0000049071-17-000091 · edgar.xml · derivative · entry 3

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,996

Underlying: Humana Common · 150 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 30, 2017 Filed Apr 3, 2017 21:05 UTC GiftHumana Common 121 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000090 · edgar.xml · nonDerivative · entry 1

MURRAY JAMES E · CIK 0001018658 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,668

Read SEC document
March 21, 2017 Filed Mar 22, 2017 17:01 UTC
BILNEY JODY LSVP & Chief Consumer Officer
SaleHumana Common 4,348 $213.80 $929,619.79
Disclosure

SEC source: 0000049071-17-000085 · edgar.xml · nonDerivative · entry 1

BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,578

F8 · price: All shares sold at this price.

Read SEC document
March 21, 2017 Filed Mar 23, 2017 20:47 UTC
Zipperle Cynthia HVice President, CAO,Controller
OtherPhantom Stock Units · Derivative 6 $213.55 $1,281.30
Disclosure

SEC source: 0000049071-17-000088 · edgar.xml · derivative · entry 7

Zipperle Cynthia H · CIK 0001628102 · Vice President, CAO,Controller

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 243

Underlying: Humana Common · 6 shares

Expires not disclosed

F7 · security: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
March 21, 2017 Filed Mar 23, 2017 20:46 UTC OtherPhantom Stock Units · Derivative 200 $213.55 $42,710.00
Disclosure

SEC source: 0000049071-17-000087 · edgar.xml · derivative · entry 7

MURRAY JAMES E · CIK 0001018658 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 200

Underlying: Humana Common · 200 shares

Expires not disclosed

F7 · security: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F7 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
March 21, 2017 Filed Mar 23, 2017 20:39 UTC
Wheatley Timothy AlanPresident, Retail Segment
OtherPhantom Stock Units · Derivative 3 $213.55 $640.65
Disclosure

SEC source: 0000049071-17-000086 · edgar.xml · derivative · entry 9

Wheatley Timothy Alan · CIK 0001699799 · President, Retail Segment

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 108

Underlying: Humana Common · 3 shares

Expires not disclosed

F9 · security: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 16:09 UTC
Kay Christopher E.SVP & Chief Innovation Officer
Exercise / conversionRestricted Stock Units · Derivative 2,929 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000080 · edgar.xml · derivative · entry 6

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 2,929 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17.

F5 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 16:09 UTC
Kay Christopher E.SVP & Chief Innovation Officer
Tax withholdingHumana Common 2,502 $218.82 $547,481.39
Disclosure

SEC source: 0000049071-17-000080 · edgar.xml · nonDerivative · entry 2

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,335

Read SEC document
March 17, 2017 Filed Mar 21, 2017 16:09 UTC
Kay Christopher E.SVP & Chief Innovation Officer
Exercise / conversionHumana Common 6,134 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000080 · edgar.xml · nonDerivative · entry 1

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,837

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · balance_after: Includes both time based (2,929) and performance based (3,205) restricted stock units that vested on 3/17/17.

Read SEC document
March 17, 2017 Filed Mar 27, 2017 14:22 UTC Amendment
Kay Christopher E.SVP & Chief Innovation Officer
Exercise / conversionRestricted Stock Units · Derivative 2,929 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000089 · edgar.xml · derivative · entry 6

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 2,929 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17.

F5 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17.

Read SEC document
March 17, 2017 Filed Mar 27, 2017 14:22 UTC Amendment
Kay Christopher E.SVP & Chief Innovation Officer
Tax withholdingHumana Common 2,528 $218.82 $553,170.64
Disclosure

SEC source: 0000049071-17-000089 · edgar.xml · nonDerivative · entry 2

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,361

Read SEC document
March 17, 2017 Filed Mar 27, 2017 14:22 UTC Amendment
Kay Christopher E.SVP & Chief Innovation Officer
Exercise / conversionHumana Common 6,186 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000089 · edgar.xml · nonDerivative · entry 1

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · balance_after: Includes both time based (2,929) and performance based (3,257) restricted stock units that vested on 3/17/17. Amendment filed to correct a scrivener's error in the reported number of performance based shares that vested.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:45 UTC
Christopher M TodoroffSr. VP and General Counsel
GrantRestricted Stock Units · Derivative 3,564 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000079 · edgar.xml · derivative · entry 6

Christopher M Todoroff · CIK 0001441437 · Sr. VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,564

Underlying: Humana Common · 3,564 shares

Expires not disclosed

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:45 UTC
Christopher M TodoroffSr. VP and General Counsel
GrantOptions · Derivative 15,498 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000079 · edgar.xml · derivative · entry 4

Christopher M Todoroff · CIK 0001441437 · Sr. VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,498

Underlying: Humana Common · 15,498 shares

Expires 2024-03-08

F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:37 UTC
BROUSSARD BRUCE DDirector · President & CEO
GrantRestricted Stock Units · Derivative 21,272 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000078 · edgar.xml · derivative · entry 6

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,272

Underlying: Humana Common · 21,272 shares

Expires not disclosed

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments.

F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:37 UTC
BROUSSARD BRUCE DDirector · President & CEO
GrantOptions · Derivative 92,489 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000078 · edgar.xml · derivative · entry 4

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,489

Underlying: Humana Common · 92,489 shares

Expires 2024-03-08

F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:34 UTC
LeClaire Brian P.SVP & Chief Information Off.
GrantRestricted Stock Units · Derivative 5,346 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000077 · edgar.xml · derivative · entry 7

LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,346

Underlying: Humana Common · 5,346 shares

Expires not disclosed

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:34 UTC
LeClaire Brian P.SVP & Chief Information Off.
GrantOptions · Derivative 23,247 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000077 · edgar.xml · derivative · entry 5

LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,247

Underlying: Humana Common · 23,247 shares

Expires 2024-03-08

F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.

F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:28 UTC
Kay Christopher E.SVP & Chief Innovation Officer
GrantRestricted Stock Units · Derivative 2,529 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000075 · edgar.xml · derivative · entry 7

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,529

Underlying: Humana Common · 2,529 shares

Expires not disclosed

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:28 UTC
Kay Christopher E.SVP & Chief Innovation Officer
GrantOptions · Derivative 10,998 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000075 · edgar.xml · derivative · entry 4

KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,998

Underlying: Humana Common · 10,998 shares

Expires 2024-03-08

F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:31 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
GrantRestricted Stock Units · Derivative 4,483 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000076 · edgar.xml · derivative · entry 7

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,483

Underlying: Humana Common · 4,483 shares

Expires not disclosed

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:31 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
GrantOptions · Derivative 19,497 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000076 · edgar.xml · derivative · entry 5

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,497

Underlying: Humana Common · 19,497 shares

Expires 2024-03-08

F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:24 UTC
Kane Brian ASVP & Chief Financial Officer
GrantRestricted Stock Units · Derivative 6,898 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000074 · edgar.xml · derivative · entry 7

Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,898

Underlying: Humana Common · 6,898 shares

Expires not disclosed

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 4,599 shares vesting in three annual increments, and 2,299 shares fully vest three years from the date of grant.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 4,599 shares vesting in three annual increments, and 2,299 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:24 UTC
Kane Brian ASVP & Chief Financial Officer
GrantOptions · Derivative 29,995 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000074 · edgar.xml · derivative · entry 4

Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,995

Underlying: Humana Common · 29,995 shares

Expires 2024-03-08

F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 19,997 options vesting in three annual increments, and 9,998 options fully vest three years from the date of grant.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 19,997 options vesting in three annual increments, and 9,998 options fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:20 UTC
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
GrantRestricted Stock Units · Derivative 4,483 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000073 · edgar.xml · derivative · entry 7

HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,483

Underlying: Humana Common · 4,483 shares

Expires not disclosed

F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan.

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:20 UTC
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
GrantOptions · Derivative 19,497 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000073 · edgar.xml · derivative · entry 5

HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,497

Underlying: Humana Common · 19,497 shares

Expires 2017-03-08

F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant.

F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:17 UTC
Zipperle Cynthia HVice President, CAO,Controller
GrantRestricted Stock Units · Derivative 3,345 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000072 · edgar.xml · derivative · entry 6

Zipperle Cynthia H · CIK 0001628102 · Vice President, CAO,Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,345

Underlying: Humana Common · 3,345 shares

Expires not disclosed

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,230 shares vesting in three annual increments, and 1,115 shares fully vest three years from the date of grant.

F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,230 shares vesting in three annual increments, and 1,115 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:09 UTC
BILNEY JODY LSVP & Chief Consumer Officer
GrantRestricted Stock Units · Derivative 5,346 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000071 · edgar.xml · derivative · entry 7

BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,346

Underlying: Humana Common · 5,346 shares

Expires not disclosed

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:09 UTC
BILNEY JODY LSVP & Chief Consumer Officer
GrantOptions · Derivative 23,247 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000071 · edgar.xml · derivative · entry 5

BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,247

Underlying: Humana Common · 23,247 shares

Expires 2024-03-08

F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.

F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:06 UTC
Huval Timothy S.Senior VP & Chief HR Officer
GrantRestricted Stock Units · Derivative 5,346 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000070 · edgar.xml · derivative · entry 6

Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,346

Underlying: Humana Common · 5,346 shares

Expires not disclosed

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant.

F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 22:06 UTC
Huval Timothy S.Senior VP & Chief HR Officer
GrantOptions · Derivative 23,247 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000070 · edgar.xml · derivative · entry 4

Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,247

Underlying: Humana Common · 23,247 shares

Expires 2024-03-08

F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 21:58 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
GrantRestricted Stock Units · Derivative 3,678 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000069 · edgar.xml · derivative · entry 8

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,678

Underlying: Humana Common · 3,678 shares

Expires not disclosed

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,529 shares vesting in three annual increments, and 1,149 shares fully vest three years from the date of grant.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,529 shares vesting in three annual increments, and 1,149 shares fully vest three years from the date of grant.

Read SEC document
March 08, 2017 Filed Mar 10, 2017 21:58 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
GrantOptions · Derivative 15,997 $0.00 Strike: $217.42 $0.00
Disclosure

SEC source: 0000049071-17-000069 · edgar.xml · derivative · entry 6

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,997

Underlying: Humana Common · 15,997 shares

Expires 2024-03-08

F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 10,998 options vesting in three annual increments, and 4,999 options fully vest three years from the date of grant.

F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 10,998 options vesting in three annual increments, and 4,999 options fully vest three years from the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.